The Patent Finder

Aegis Therapeutics, LLC

15 patents currently held · Updated Nov 17, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

7
Ending by 2030
Apr 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Intranasal epinephrine formulations and methods for the treatment of disease (US 11,717,571) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Intranasal Epinephrine Formulations and Methods for the Treatment of Disease (US 11,744,895) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 2 fees due Sep 3 to 5, 2027 · next Sep 3

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,084,022Stabilizing Alkylglycoside Compositions and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,173,594Stabilizing Alkylglycoside Compositions and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,226,949Stabilizing Alkylglycoside Compositions and Methods Thereof
In force
 · High confidence
In forceHigh confidence
US 8,133,863Stabilizing Alkylglycoside Compositions and Methods Thereof
In force
 · High confidence
In forceHigh confidence
US 8,076,290Stabilizing Alkylglycoside Compositions and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,642,564Compositions for Drug Administration
In force
 · Medium confidence
In forceMedium confidence
US 8,470,370Controlled Release Formulations
In force
 · High confidence
In forceHigh confidence
US 10,576,156Compositions for Drug Administration
In force
 · High confidence
In forceHigh confidence
US 11,173,209Compositions for Drug Administration
In force
 · High confidence
In forceHigh confidence
US 10,682,414Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
In force
 · Medium confidence
In forceMedium confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
Also on record, not counted in the 15: 3 patents in force now held by others · 1 lapsed for an unpaid fee · 16 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 abandoned · 25 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited